* Entered into privately-negotiated conversion agreements
with certain holders of 4.50% convertible senior notes due 2020
The post BRIEF-Merrimack Pharma enters privately-negotiated conversion agreements with certain holders of 4.50 pct convertible senior notes due 2020 appeared first on NASDAQ.